Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David A Learmonth

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
Bioconjugate Chemistry|January 16, 2003
A concise synthesis of the 3-O-beta-D- and 4'-O-beta-D-glucuronide conjugates of trans-resveratrolDavid A Learmonth
Bioconjugate Chemistry|September 19, 2002
Chemical synthesis and characterization of conjugates of a novel catechol-O-methyltransferase inhibitorDavid A Learmonth, Ana P Freitas
Organic Letters|April 11, 2008
Efficient synthesis of 2-(trifluoromethyl)nicotinic acid derivatives from simple fluorinated precursorsLászló E Kiss, Humberto S Ferreira, David A Learmonth
Journal of Medicinal Chemistry|February 3, 2006
Synthesis and biological evaluation of novel, peripherally selective chromanyl imidazolethione-based inhibitors of dopamine beta-hydroxylaseAlexandre Beliaev, David A Learmonth, Patricio Soares-da-Silva
Journal of Medicinal Chemistry|December 13, 2005
Synthesis and biological evaluation of a novel series of "ortho-nitrated" inhibitors of catechol-O-methyltransferaseDavid A Learmonth, Maria João Bonifácio, Patrício Soares-da-Silva
International Review of Neurobiology|November 25, 2010
The chemistry of catechol-O-methyltransferase inhibitorsDavid A Learmonth, László E Kiss, Patrício Soares-da-Silva
Frontiers in Pharmacology|March 15, 2018
The Role of Biomaterials as Angiogenic Modulators of Spinal Cord Injury: Mimetics of the Spinal Cord, Cell and Angiogenic Factor Delivery AgentsLuís A Rocha, Rui A Sousa, David A Learmonth, et al.
Biotechnology Advances|November 21, 2017
αvβ3 and α5β1 integrin-specific ligands: From tumor angiogenesis inhibitors to vascularization promoters in regenerative medicine?Luís A Rocha, David A Learmonth, Rui A Sousa, et al.
Journal of Medicinal Chemistry|November 30, 2004
Synthesis, biological evaluation, and molecular modeling studies of a novel, peripherally selective inhibitor of catechol-O-methyltransferaseDavid A Learmonth, P Nuno Palma, Maria A Vieira-Coelho, et al.
Knee Surgery, Sports Traumatology, Arthroscopy : Official Journal of the ESSKA|January 3, 2020
Enhanced microfracture using acellular scaffolds improves results after treatment of symptomatic focal grade III/IV knee cartilage lesions but current clinical evidence does not allow unequivocal recommendationCristiana Branco da Cunha, Renato Andrade, Tiago Rafael Veloso, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Bioconjugate Chemistry|January 16, 2003
A concise synthesis of the 3-O-beta-D- and 4'-O-beta-D-glucuronide conjugates of trans-resveratrolDavid A Learmonth
Bioconjugate Chemistry|September 19, 2002
Chemical synthesis and characterization of conjugates of a novel catechol-O-methyltransferase inhibitorDavid A Learmonth, Ana P Freitas
Organic Letters|April 11, 2008
Efficient synthesis of 2-(trifluoromethyl)nicotinic acid derivatives from simple fluorinated precursorsLászló E Kiss, Humberto S Ferreira, David A Learmonth
Journal of Medicinal Chemistry|February 3, 2006
Synthesis and biological evaluation of novel, peripherally selective chromanyl imidazolethione-based inhibitors of dopamine beta-hydroxylaseAlexandre Beliaev, David A Learmonth, Patricio Soares-da-Silva
Journal of Medicinal Chemistry|December 13, 2005
Synthesis and biological evaluation of a novel series of "ortho-nitrated" inhibitors of catechol-O-methyltransferaseDavid A Learmonth, Maria João Bonifácio, Patrício Soares-da-Silva
International Review of Neurobiology|November 25, 2010
The chemistry of catechol-O-methyltransferase inhibitorsDavid A Learmonth, László E Kiss, Patrício Soares-da-Silva
Frontiers in Pharmacology|March 15, 2018
The Role of Biomaterials as Angiogenic Modulators of Spinal Cord Injury: Mimetics of the Spinal Cord, Cell and Angiogenic Factor Delivery AgentsLuís A Rocha, Rui A Sousa, David A Learmonth, et al.
Biotechnology Advances|November 21, 2017
αvβ3 and α5β1 integrin-specific ligands: From tumor angiogenesis inhibitors to vascularization promoters in regenerative medicine?Luís A Rocha, David A Learmonth, Rui A Sousa, et al.
Journal of Medicinal Chemistry|November 30, 2004
Synthesis, biological evaluation, and molecular modeling studies of a novel, peripherally selective inhibitor of catechol-O-methyltransferaseDavid A Learmonth, P Nuno Palma, Maria A Vieira-Coelho, et al.
Knee Surgery, Sports Traumatology, Arthroscopy : Official Journal of the ESSKA|January 3, 2020
Enhanced microfracture using acellular scaffolds improves results after treatment of symptomatic focal grade III/IV knee cartilage lesions but current clinical evidence does not allow unequivocal recommendationCristiana Branco da Cunha, Renato Andrade, Tiago Rafael Veloso, et al.
Pageof 2